Generating golden Syrian hamsters with conditional alleles via zygote microinjection of CRISPR/Cas9

Abstract

Background: The golden Syrian hamster is a valuable animal model for studying carcinogenesis, metabolic disorders, cardiovascular diseases, and viral infections due to its biological and pathological similarities to humans. However, the development of genetically engineered hamsters has lagged behind that of mice and rats, largely because of an embryonic development block at the two-cell stage in vitro. Although CRISPR/Cas9-mediated gene knockout has been achieved in hamsters, precise DNA fragment insertion or conditional knockout (cKO) models have not previously been reported, likely due to technical limitations in embryo manipulation and insufficient efficiency of homology-directed repair (HDR).

Methods: In this study, we generated conditional alleles of the ApoF gene in golden Syrian hamsters. A two-cut strategy was applied using Cas9 protein, two sgRNAs, and a single donor plasmid containing exon 2 flanked by loxP sites and two ~0.8 kb homology arms. A mixture of Cas9 protein, sgRNAs, and the donor plasmid was microinjected into the pronuclei of one-cell stage hamster embryos.

Results: The efficiency of CRISPR/Cas9-mediated loxP knock-in reached up to 27%, and the genetically modified floxed alleles were successfully transmitted through the germline. The functionality of the inserted loxP sites was validated by in vivo Cre-mediated recombination following local administration of AAV vectors, including AAV-cTnT-Cre in the heart and AAV-CMV-Cre in the brain.

Conclusions: To our knowledge, this work represents the first successful establishment of a conditional knockout model in the golden Syrian hamster, providing a valuable tool for mechanistic studies of gene function and disease modeling.

Keywords

conditional knockout / genome editing / Golden Syrian hamster

References

[1] Wang X, Ramat A, Simonelig M, Liu MF. Emerging roles and functional mechanisms of PIWI-interacting RNAs. Nat Rev Mol Cell Biol. 2023; 24(2): 123-141.

[2] Wang Z, Cormier RT. Golden Syrian hamster models for cancer research. Cells. 2022; 11(15):2395.

[3] Xian X, Wang Y, Liu G. Genetically engineered hamster models of dyslipidemia and atherosclerosis. Methods Mol Biol. 2022; 2419: 433-459.

[4] Wang S, Li W, Wang Z, et al. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control. Signal Transduct Target Ther. 2024; 9(1):223.

[5] Gao M, Zhang B, Liu J, et al. Generation of transgenic golden Syrian hamsters. Cell Res. 2014; 24(3): 380-382.

[6] Takenaka M, Horiuchi T, Yanagimachi R. Effects of light on development of mammalian zygotes. Proc Natl Acad Sci USA. 2007; 104(36): 14289-14293.

[7] Hirose M, Tomishima T, Ogura A. Editing the genome of the Golden hamster (Mesocricetus auratus). Methods Mol Biol. 2023; 2637: 247-254.

[8] Li R, Ying B, Liu Y, et al. Generation and characterization of an Il2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients. Dis Model Mech. 2020; 13(8):dmm044602.

[9] Wang H, Yang H, Shivalila CS, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013; 153(4): 910-918.

[10] Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell. 2013; 154(6): 1370-1379.

[11] Ma Y, Ma J, Zhang X, et al. Generation of eGFP and Cre knockin rats by CRISPR/Cas9. FEBS J. 2014; 281(17): 3779-3790.

[12] Ma Y, Zhang X, Shen B, et al. Generating rats with conditional alleles using CRISPR/Cas9. Cell Res. 2014; 24(1): 122-125.

[13] Fan Z, Li W, Lee SR, et al. Efficient gene targeting in golden Syrian hamsters by the CRISPR/Cas9 system. PLoS One. 2014; 9(10):e109755.

[14] Guo X, Gao M, Wang Y, et al. LDL receptor gene-ablated hamsters: a rodent model of familial hypercholesterolemia with dominant inheritance and diet-induced coronary atherosclerosis. EBioMedicine. 2018; 27: 214-224.

[15] Li R, Miao J, Tabaran AF, et al. A novel cancer syndrome caused by KCNQ1-deficiency in the golden Syrian hamster. J Carcinog. 2018; 17:6.

[16] Miao J, Lan T, Guo H, et al. Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system. Animal Model Exp Med. 2023; 6(5): 489-498.

[17] Shen B, Zhang J, Wu H, et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res. 2013; 23(5): 720-723.

[18] Nakayama T, Noda Y, Goto Y, Mori T. Effects of visible light and other environmental factors on the production of oxygen radicals by hamster embryos. Theriogenology. 1994; 41(2): 499-510.

[19] Ittner LM, Götz J. Pronuclear injection for the production of transgenic mice. Nat Protoc. 2007; 2(5): 1206-1215.

[20] Zheng P, Wang H, Bavister BD, Ji W. Maturation of rhesus monkey oocytes in chemically defined culture media and their functional assessment by IVF and embryo development. Hum Reprod. 2001; 16(2): 300-305.

[21] Deprince A, Hennuyer N, Kooijman S, et al. Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism. Hepatology. 2023; 77(4): 1287-1302.

[22] Liu Y, Morton RE, Apolipoprotein F. A natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism. Curr Opin Lipidol. 2020; 31(4): 194-199.

[23] Chan JF, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a Golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020; 71(9): 2428-2446.

[24] Wang C, Cheng Z, Miao J, et al. Genomic-transcriptomic analysis identifies the Syrian hamster as a superior animal model for human diseases. BMC Genomics. 2025; 26(1):286.

[25] Imai M, Iwatsuki-Horimoto K, Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci USA. 2020; 117(28): 16587-16595.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.